Sector
PharmaceuticalsOpen
₹2,088Prev. Close
₹2,080.2Turnover(Lac.)
₹3,738.94Day's High
₹2,156.8Day's Low
₹2,07552 Week's High
₹2,64152 Week's Low
₹1,365Book Value
₹227.55Face Value
₹2Mkt Cap (₹ Cr.)
15,840.84P/E
46.68EPS
44.66Divi. Yield
0.267 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
7 Aug 2024
12:00 AM
AGM
Announcement Date: 07 Aug, 2024
The drug is the generic alternative of the Vitamin K1 Injection produced by Hospira Inc and is indicated in the treatment of Vitamin K deficiency-related coagulation disorders.
Here are some of the stocks that may see significant price movement today: ICICI Prudential, Caplin Point, Ashoka Buildcon, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 15.19 | 15.18 | 15.16 | 15.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,374.96 | 1,124.73 | 915.49 | 743.54 |
Net Worth | 1,390.15 | 1,139.91 | 930.65 | 758.67 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 482.67 | 527.82 | 426.57 | 341.54 |
yoy growth (%) | -8.55 | 23.73 | 24.89 | 47.67 |
Raw materials | -194.83 | -238.17 | -180.11 | -161.93 |
As % of sales | 40.36 | 45.12 | 42.22 | 47.41 |
Employee costs | -26.59 | -24.99 | -38.82 | -30.58 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 209.93 | 253.12 | 146.05 | 92.57 |
Depreciation | -22.44 | -19.65 | -18.98 | -13.25 |
Tax paid | -53.71 | -55.48 | -43.74 | -22.26 |
Working capital | 168.2 | 177.62 | 44.02 | 40.41 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -8.55 | 23.73 | 24.89 | 47.67 |
Op profit growth | 3.34 | 45.98 | 51.72 | 49.97 |
EBIT growth | -17.05 | 73.36 | 57.61 | 58.5 |
Net profit growth | -20.95 | 93.17 | 45.49 | 55.13 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,937.47 | 1,694.1 | 1,466.73 | 1,269.41 | 1,061.29 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,937.47 | 1,694.1 | 1,466.73 | 1,269.41 | 1,061.29 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 96.43 | 67.21 | 56.06 | 38.75 | 23.54 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
C C Paarthipan
Independent Director
D Sathyanarayanan
Independent Director
C K Gariyali
Independent Director
Deenadayalan Singaram
Independent Director
R Nagendran
Managing Director
Sridhar Ganesan
Company Sec. & Compli. Officer
Venkatram G
Independent Director
R Vijayaraghavan
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Tamil Nadu - 600096
Tel: 91-44-24968000/71148000/28156653
Website: http://www.caplinpoint.net
Email: [email protected]; [email protected]
2nd Floor Kences Tow,
1 Ramakrishna Street, Usman Road T.Nagar,
Chennai-600017
Tel: 91-44-28140801/803
Website: www.integratedindia.in
Summary
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990. The Company is a fully integrated Pharma Company and is presently into the business of pharmaceu...
Read More
Reports by Caplin Point Laboratories Ltd
What is the Caplin Point Laboratories Ltd share price today?
What is the Market Cap of Caplin Point Laboratories Ltd?
What is the PE and PB ratio of Caplin Point Laboratories Ltd?
What is the 52 Week High and Low of Caplin Point Laboratories Ltd?
What is the CAGR of Caplin Point Laboratories Ltd?
What is the shareholding pattern of Caplin Point Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
